Costimulation by B7-1 and LFA-3 targets distinct nuclear factors that bind to the interleukin-2 promoter: B7-1 negatively regulates LFA-3-induced NF-AT DNA binding

Molecular and Cellular Biology

Volumn 17, Issue 3, 1997, Pages 1314-1323

  Parra, Eduardo ^a   Varga, Mikael ^b   Hedlund, Gunnar ^a,b   Kalland, Terje ^a,b   Dohlsten, Mikael ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b Pharmacia & Upjohn AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; HLA DR3 ANTIGEN; INTERLEUKIN 2; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; NUCLEAR FACTOR; SUPERANTIGEN;

ARTICLE; CELL CULTURE; DNA BINDING; ENHANCER REGION; ENZYME ACTIVITY; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0031018905     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.3.1314     Document Type: Article

References (59)

1. Allison, J. P. 1994. CD28/B7 interaction in T cell activation. Curr. Opin. Immunol. 6:414-419.
2. Angel, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729-739.
3. Beg, A. A., and A. S. Baldwin. 1993. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7:1564-1570.
4. Bierer, B. E., S. Herrmann, and S. J. Burakoff. 1988. Interaction of CD2 with its ligand, LFA-3 in human T cell proliferation. J. Immunol. 140:3358-3362.
5. Bours, V., G. Franzoso, V. Azarenko, S. Park, T. Kanno, K. Brown, and U. Siebenlist. 1993. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell 72:729-739.
6. Boussiotis, V. A., G. J. Freeman, J. D. Griffin, G. S. Gray, J. G. Gribben, and L. M. Nadler. 1994. CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy. J. Exp. Med. 180:1665-1673.
7. Brabletz, T., I. Pietrowsky, and E. Serfling. 1991. The immunosuppressive FK-506 and cyclosporin A inhibit the generation of protein factors binding to the two purine boxes of the interleukin 2 enhancer. Nucleic Acids Res. 19:61-67.
8. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-1488.
9. Bryan, R. G., Y. Li, J.-H. Lai, M. Van, N. R. Rice, R. R. Rich, and T.-H. Tan. 1994. Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells. Mol. Cell. Biol. 14:7933-7942.
10. Castigli, E., T. A. Chatila, and R. S. Geha. 1993. A protein of the AP-1 family is a component of nuclear factor of activated T cells. J. Immunol. 150:3284-3290.
11. Choi, M. S. K., R. D. Brines, M. J. Holman, and G. G. B. Klaus. 1994. Induction of NF-AT in normal B lymphocytes by anti-immunoglobulin or CD40 ligand in conjunction with IL-4. Immunity 1:179-187.
12. Civil, A., M. Geerts, L. A. Aarden, and C. L. Verweij. 1992. Evidence for a role of CD28RE as a response element for distinct mitogenic T cell activation signal. Eur. J. Immunol. 22:3041-3043.
13. De Grazia, U., M. P. Felli, A. Vacca, A. R. Farina, M. Maroder, L. Cappabianca, D. Meco, M. Farina, I. Screpanti, L. Frati, and A. Gulino. 1994. Positive and negative regulation of the composite octamer motif of the interleukin 2 enhancer by AP-1, Oct-2, and retinoic acid receptor. J. Exp. Med. 180:1485-1497.
14. Durand, D. B., J.-P. Shaw, M. R. Bush, R. E. Replogle, R. Belagaje, and G. R. Crabtree. 1988. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8:1715-1724.
15. Dustin, M., M. Sanders, S. Shaw, and T. Springer. 1987. Purified lymphocyte function-associated antigen 333 binds to CD2 and mediates T lymphocyte adhesion. J. Exp. Med. 165:677-692.
16. Fischer, H., G. Hedlund, T. Kalland, H. O. Sjögren, and M. Dohlsten. 1990. Independent regulation of IFN-γ and tumor necrosis factor by IL-1 in human T helper cells. J. Immunol. 145:3767-3771.
17. Fraser, J. D., and A. Weiss. 1992. Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28. Mol. Cell. Biol. 12:4357-4363.
18. Fraser, J. D., B. A. Irving, G. R. Crabtree, and A. Weiss. 1991. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251:313-316.
19. Ghos, P., T. Tan, N. R. Rice, A. Sica, and H. A. Young. 1993. The interleukin 2 CD28-responsive complex contains at least three members of the κB family: c-Rel, p50 and p65. Proc. Natl. Acad. Sci. USA 90:1696-1700.
20. + T cell subsets. Scand. J. Immunol. 36:243-250.
21. Granelli-Piperno, A., and P. Nolan. 1991. Nuclear transcription factors that bind to elements of the IL-2 promoter. J. Immunol. 147:2734-2739.
22. Grilli, M., J.-S. Jason, and M. J. Lenardo. 1993. NF-κB and rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1-62.
23. Grimm, S., and P. A. Baeuerle. 1993. The inducible transcription factor NF-κB: structure-function relationship of its protein subunits. Biochem. J. 290:297-308.
24. Harding, F. A., J. G. McArthur, J. A. Gross, D. H. Raluet, and J. P. Allison. 1992. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607-609.
25. Hay, R. T. 1993. Control of nuclear factor-κB DNA binding activity by inhibitor proteins containing ankyrin repeats. Biochem. Soc. Trans. 21:926-930.
26. Jain, J., P. G. McCaffrey, V. E. Valge-Archer, and A. Rao. 1992. Nuclear factor of activated T cells contains Fos and Jun. Nature 356:801-804.
27. Jain, J., P. G. McCaffrey, Z. Miner, T. K. Kerppola, J. N. Lambert, G. L. Verdine, T. Curran, and A. Rao. 1993. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 365:352-355.
28. Jain, J., E. Burgeon, T. M. Badalian, P. G. Hogan, and A. Rao. 1995. A similar DNA-binding motif in NF-AT family proteins and the Rel homology region. J. Biol. Chem. 270:4138-4145.
29. Jain, J., Z. Miner, and A. Rao. 1993. Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells. J. Immunol. 151:837-848.
30. Janeway, C. 1989. Immunogenicity signals 1, 2, 3 . . . and 0. Immunol. Today 10:283-286.
31. Janeway, C. A., and M. Golstein. 1993. Lymphocyte activation and effector functions. The role of cell surface molecules. Curr. Opin. Immunol. 5:313-323.
32. Jenkins, M. K., and J. G. Johnson. 1993. Molecules involved in T-cell costimulation. Curr. Opin. Immunol. 5:361-367.
33. June, C. H., A. Jeffrey, A. Ledbetter, P. S. Linsley, and C. B. Thompson. 1990. Role of the CD28 receptor in T-cell activation. Immunol. Today 11:211-216.
34. Kamps, M. P., L. Corcoran, J. H. LeBowitz, and D. Baltimore. 1990. The promoter of the human interleukin-2 gene contains two octamer-binding sites and is partially activated by the expression of Oct-2. Mol. Cell. Biol. 10:5464-5472.
35. Koyasu, S., T. Lawton, D. Novick, M. A. Recny, F. Siliciano, B. P. Wallner, and E. L. Reinherz. 1990. Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen. Proc. Natl. Acad. Sci. USA 87:2603-2607.
36. Lai, J.-H., G. Horvath, J. Subleski, J. Bruder, P. Ghosh, and T.-H. Tan. 1995. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter. Mol. Cell. Biol. 15:4260-4271.
37. Lee, W., P. Mitchell, and R. Tjian. 1987. Purified transcriptional factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49:741-752.
38. Lindsten, T., C. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339-343.
39. Liou, H. C., and D. Baltimore. 1993. Regulation of the NF-κB/rel transcription factor and IκB inhibitor system. Curr. Opin. Cell Biol. 5:477-487.
40. Mattila, P. S., K. S. Ullman, S. Fiering, E. A. Emmel, M. McCutcheon, G. R. Crabtree, and L. A. Herzenberg. 1990. The actions of cyclosporin A and FK-506 suggest a novel step in the activation of T lymphocytes. EMBO J. 9:4425-4433.
41. McCaffrey, P. G., C. Luo, T. K. Kerppola, J. Jain, T. M. Badalian, A. M. Ho, E. Burgeon, W. S. Lane, J. N. Lambert, T. Curran, G. L. Verdine, A. Rao, and P. G. Hogan. 1993. Isolation of the cyclosporin-sensitive T cell transcription factor NF-ATp. Science 262:750-754.
42. Northrop, J. P., S. N. Ho, L. Chen, D. J. Thomas, L. A. Timmerman, G. P. Nolan, A. Admon, and G. R. Crabtree. 1994. NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369:497-502.
43. Parra, E., A. Gjörloff-Wingren, G. Hedlund, M. Björklund, H. O. Sjögren, T. Kalland, D. Sansom, and M. Dohlsten. 1994. Costimulation of human CD4+ T lymphocytes with B7 and LFA-3 results in distinct cell activation profiles. J. Immunol. 153:2479-2487.
44. + T cells with LFA-3 and B7 induce distinct effects on AP-1 and NF-κB transcription factors. J. Immunol. 155:1132-1140.
45. Rao, A. 1994. NF-ATp: a transcription factor required for the coordinate induction of several cytokine genes. Immunol. Today 15:274-281.
46. Rincón, M., and R. A. Flavell. 1994. AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J. 13:4370-4381.
47. Rooney, J. W., Y.-L. Sun, L. H. Glimcher, and T. Hoey. 1995. Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol. Cell. Biol. 15:6299-6310.
48. Samelson, L. E. 1989. Lymphocyte activation. Curr. Opin. Immunol. 2:210-214.
49. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res. 17:6419.
50. Schwartz, R. H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4 and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71:1065-1068.
51. Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705-716.
52. Shaw, J.-P., P. J. Utz, D. B. Durand, J. J. Toole, E. A. Emmel, and G. R. Crabtree. 1988. Identification of a putative regulator of early T cell activation genes. Science 241:202-205.
53. Stein, B., A. S. Baldwin, Jr., D. W. Ballard, W. C. Greene, P. Angel, and P. Herrlich. 1993. Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12:3879-3891.
54. Traeckner, E. B.-M., H. Pahl, T. Henkel, K. N. Schmidt, S. Wilk, and P. A. Baeuerle. 1995. Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 14:2876-2883.
55. Turcovski-Corrales, S. M., R. G. Fenton, G. Peltz, and D. D. Taub. 1995. CD28:B7 interaction promote T cell adhesion. Eur. J. Immunol. 25:3087-3093.
56. Umlauf, S. W., B. Beverly, S.-M. Kang, K. Brorson, A.-C. Tran, and R. H. Schwartz. 1993. Molecular regulation of the IL-2 gene: rheostatic control of the immune system. Immunol. Rev. 133:177-195.
57. Venkataraman, L., D. A. Francis, Z. Wang, J. Liu, T. L. Rothstein, and R. Sen. 1994. Cyclosporin-A sensitive induction of NF-AT in murine B cells. Immunity 1:189-196.
58. Verweij, C. L., M. Geerts, and L. A. Aarden. 1991. Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-κB-like response element. J. Biol. Chem. 266:14179-14182.
59. Yiling, L., A. Granelli-Piperno, J. M. Bjorndahl, C. A. Phillips, and J. M. Trevillyan. 1992. CD28-induced T cell activation. J. Immunol. 149:24-29.